CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- 4 Open-market buy 10% owner bought 250,000 shares at $24.00 ($6,000,000)
- 4 Open-market buy Director bought 250,000 shares at $24.00 ($6,000,000)
- 4 Conversion Director acquired 11,295 shares (conversion)
- 4 Open-market buy Director bought 41,666 shares at $24.00 ($999,984)
- 4 Conversion See Remarks acquired 133,004 shares (conversion)
- 4 Conversion President, CEO, and Chairman acquired 750,000 shares (conversion)
- 4 Conversion 10% owner acquired 176,862 shares (conversion)
- 4 Conversion Chief Commercial Officer acquired 82,508 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 14 of 16 · 316 filings